SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: contrarian who wrote (1410)1/6/1998 11:54:00 PM
From: Bob L   of 1762
 
Sources at a large HMO in my area say Rituxan will probably be approved for coverage, but the internal review process in the HMO ordinarily takes months! The HMO approval process for Rituxan started after final FDA approval, not a minute before. If an individual patient pushes, there would probably be earlier approval for that patient. So there may a significant ramp-up time before there is widespread coverage, if this HMO is any indication.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News